{
    "Trade/Device Name(s)": [
        "Heparin Assay Controls"
    ],
    "Submitter Information": "Medtronic, Inc.",
    "510(k) Number": "K103313",
    "Predicate Device Reference 510(k) Number(s)": [
        "K894317",
        "K042206"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GGN"
    ],
    "Summary Letter Date": "December 1, 2010",
    "Summary Letter Received Date": "November 10, 2010",
    "Submission Date": "October 1, 2010",
    "Regulation Number(s)": [
        "21 CFR 864.5425"
    ],
    "Regulation Name(s)": [
        "Multipurpose system for in vitro coagulation studies"
    ],
    "Analyte Class(es)": [
        "coagulation"
    ],
    "Analyte(s)": [
        "Heparin"
    ],
    "Specimen Type(s)": [
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "HMS Plus",
        "Heparin Assay Cartridges"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Medtronic Heparin Assay Controls using revised USP heparin in plasma to verify performance of HMS Plus and Heparin Assay Cartridges",
    "Indications for Use Summary": "To verify the performance of the HMS Plus and Heparin Assay Cartridges; for In Vitro Diagnostic use",
    "fda_folder": "Hematology"
}